In September last year, we reported Servier had advanced its emerging neurology pipeline into the clinical trials stage by ...
Researchers built an immune-aging clock from 1.2 million cells, revealing T cells as key indicators of immune aging. They ...
As a wave of plans for low Earth orbit (LEO) broadband constellations enters the market, a 63-year-old former NASA Branch Chief and Google executive is betting on narrow beams, higher frequencies and ...
Can your gut bacteria control your stress? Microbial diversity and short-chain fatty acids are linked to acute cortisol ...
How does the placebo effect work? A new study identifies the vlPAG brain region and endogenous opioid signaling as the keys to expectancy-driven pain relief.
Toshiba Electronic Devices & Storage Corporation (“Toshiba”) has started to ship engineering samples of “TB9M030FG,” the ...
A new study from China reports a breakthrough metasurface-enabled terahertz (THz) imaging and spectroscopy platform that ...
SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing a fully human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune ...
In a recent study published in Nature Communications, researchers created a memristor that uses a built-in oxygen gradient to ...
Riccardo Balestri, MD, PhD, discusses his research on coexistent psoriasis and atopic dermatitis, also known as PsoDermatitis ...
ARDS / hypoxemic pneumonia Phase 2 trial initiation 1H 2026; early data by year end; market opportunity of ~200,000–300,000 ...
KT-621 BREADTH Phase 2b asthma trial ongoing, with data expected to be reported in late 2027KT-621 BROADEN2 Phase 2b atopic dermatitis (AD) trial ...